Valuation
- Valuation multiples are premium but supported by fundamental performance. The current price is considered fairly valued to slightly undervalued relative to the company's growth trajectory, with a target price range of $380-$450.
- The TTM P/E of 29.10x is elevated compared to historical market averages but must be contextualized with the company's growth profile.
- The high forward P/E of 40.77x suggests the market is pricing in significant future earnings growth, supported by recent explosive Q1 profit growth of 81%.
- The high PB ratio of 9.74x is justified by the world-class ROE of 39.40%.
- The PS ratio of 10.30x reflects the market's premium valuation for its top-line growth and market dominance.
- Using TTM EPS ($10.81) and a P/E range of 25x-35x yields a fundamental value range of $270.25 - $378.35.
- Using the Q1 annualized EPS run-rate ($20.44) with a multiple of 20x-30x provides a range of $408.80 - $613.20.
- A reasonable 12-month target price range is $380 - $450.
- The current price of $357.77 sits at the lower end of the historical earnings-based range and below the forward-looking range.
- Given stellar recent growth, high profitability, and strong financial health, the current valuation does not appear excessive.
- It can be considered fairly valued to slightly undervalued relative to its growth trajectory.